MOSCOW (MRC) -- With a level of purity approaching 99%, SEPURAN green high performance polymers from Evonik Industries make biogas processing much more efficient, according to the company's press release.
For this achievement, the company has received the 2013 German Innovation Prize for climate and the environment in the "Environmentally friendly technologies" category.
The prize is awarded by the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) and the Federation of German Industry (BDI). Dr. Dahai Yu, responsible for the Specialty Materials Segment in the Executive Board: "Innovations are a major contribution towards overcoming the challenges of the future. This also includes securing energy supplies practically from economical, ecological, and social aspects. With SEPURAN Green, Evonik shows what the chemical industry can do to make this happen."
Evonik initially trialed SEPURAN Green in a test plant beside the Vockla River in Neukirchen, Austria. Since then, several biogas processing plants using SEPURAN Green technology have been put into operation.
Evonik is also continuing to develop the SEPURAN technology for new applications, such as separating hydrogen and recovering nitrogen from compressed air.
As MRC informed previously, in late December, 2013, Evonik Industries and LanzaTech have signed a three year research cooperation agreement which will see Evonik combining its existing biotechnology platforms with LanzaTech’s synthetic biology and gas fermentation expertise for the development of a route to bio-processed precursors for specialty plastics from waste derived synthesis gas.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2012, the company generated sales of around EUR13.6 billion and an operating profit (adjusted EBITDA) of about EUR2.6 billion.
MRC